Inventor · disambiguated record
Stephen H. Thorne
Also filed as: THORNE STEPHEN · THORNE STEPHEN H · THORNE STEPHEN HOWARD
16 granted patents·18 pending applications·38 citations·filing 2006–2025
89Inventor score
Files withKALIVIR IMMUNOTHERAPEUTICS INC17UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION4UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION4UNIV LELAND STANFORD JUNIOR3CONTAG CHRISTOPHER H2
Top patents by PatentIndex Score
34 records- 0192US9101658B2Immune effector cells pre-infected with oncolytic virusCONTAG CHRISTOPHER H·Filed 2012·Granted Aug 11, 2015·19 cites·5 claims
- 0289US7687474B2Nitroreductase enzymesUNIV LELAND STANFORD JUNIOR·Filed 2006·Granted Mar 30, 2010·15 cites·11 claims
- 0384US12246049B2Oncolytic viruses targeting STAT3UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2023·Granted Mar 11, 2025·0 cites·20 claims
- 0481US11963990B2Oncolytic viruses for modified MHC expressionKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2023·Granted Apr 23, 2024·0 cites·19 claims
- 0581US2024277793A1Oncolytic viruses for modified mhc expressionKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0681US2024277794A1Oncolytic viruses for modified mhc expressionKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0780US12016893B2Oncolytic viruses for modified MHC expressionKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·0 cites·24 claims
- 0880US10064893B2Immune effector cells pre-infected with oncolytic virusUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Sep 4, 2018·2 cites·29 claims
- 0979US2025041368A1Oncolytic Immunotherapy by Tumor Micro-Environment RemodelingKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1079US2025009824A1Oncolytic Immunotherapy by Tumor Micro-Environment RemodelingKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1178US12403165B2Oncolytic immunotherapy by tumor micro-environment remodelingKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2023·Granted Sep 2, 2025·0 cites·27 claims
- 1275US12472217B2Platform oncolytic vector for systemic deliveryKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2022·Granted Nov 18, 2025·0 cites·22 claims
- 1375US11065286B2High mobility group box I mutantTHORNE STEPHEN H·Filed 2017·Granted Jul 20, 2021·1 cites·23 claims
- 1474US12318419B2Platform oncolytic vector for systemic deliveryKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2021·Granted Jun 3, 2025·0 cites·15 claims
- 1574US12226440B2Platform oncolytic vector for systemic deliveryKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2021·Granted Feb 18, 2025·0 cites·18 claims
- 1674US11478518B2Immuno-oncolytic therapiesUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2016·Granted Oct 25, 2022·1 cites·24 claims
- 1773US2022133824A1Oncolytic viruses targeting stat3UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2022·Application pending·0 cites
- 1872US2022133825A1Oncolytic viruses targeting stat3UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2022·Application pending·0 cites
- 1969US11253559B2Oncolytic viruses targeting STAT3UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2019·Granted Feb 22, 2022·0 cites·20 claims
- 2069US2019231818A1Immune effector cells pre-infected with oncolytic virusUNIV LELAND STANFORD JUNIOR·Filed 2018·Application pending·0 cites
- 2168US12036257B2Platform oncolytic vector for systemic deliveryKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2018·Granted Jul 16, 2024·0 cites·29 claims
- 2265US2021196770A1Platform oncolytic vector for systemic deliveryKaliVir Immunotherapeutics LLC·Filed 2021·Application pending·0 cites
- 2363US2025249054A1Methods of Treating CancerKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2462US2022362317A1Irf modulator-expressing oncolytic viruses for treating cancerUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2022·Application pending·0 cites
- 2561US2011160146A1Conjungation of Small Molecules to Octaarginine Transporters for Overcoming Multi-Drug ResistanceNAT INST OF HEALTH NIH·Filed 2009·Application pending·0 cites
- 2661US2022031777A1Methods of Treating CancerKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2758US2007077231A1Immune effector cells pre-infected with oncolytic virusCONTAG CHRISTOPHER H·Filed 2006·Application pending·0 cites
- 2857US2021338754A1High mobility group box i mutantTHORNE STEPHEN H·Filed 2021·Application pending·0 cites
- 2956US2022220505A1Producer Viruses for Generation of Retroviruses In SituKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3056US2025064873A1TNFSF-L Fusion Proteins and Uses ThereofKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3153US11786569B2Expression of metabolic modulators in tumor microenvironment to improve tumor therapyUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2019·Granted Oct 17, 2023·0 cites·20 claims
- 3253US2022049228A1Modified Extracellular Enveloped VirusKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3351US2025302899A1Compositions of cd47/sirp-alpha immune checkpoint inhibitors and uses thereofKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3444US12150969B2Synthetically enveloped virusUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2017·Granted Nov 26, 2024·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Stephen H. Thorne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →